We Can Help

The costs of mesothelioma can be overwhelming. They can include income loss, expensive treatments that may not be covered by health insurance, plus pain and suffering for you and for your family. Because the disease is preventable – and because it is usually caused by someone else’s negligence – legal options may be available to help regain these costs. Asbestos lawyers focus their practice on knowledgeably and effectively bringing to justice companies that exposed employees and the public to asbestos products. A mesothelioma attorney can help you consider your options and file a claim against the company responsible for your asbestos-related illness. More than one company may be responsible. A mesothelioma attorney identifies all companies at fault. Mesothelioma lawsuits have helped thousands of people receive financial assistance. A lawsuit can result in much-needed money to help reduce financial hardships during an illness and can also provide a more stable future for your loved ones. A lawyer specializing in asbestos litigation can help you seek compensation for expenses related to illness caused by asbestos exposure.

VA Benefits Now Available to Millions of Veterans

VA health care benefits are now available to millions more veterans in one of the largest expansions of coverage in the U.S. The inclusion of significantly more veterans compared to past bills comes at the direction of President Joe Biden. Veterans Who Now Qualify Benefits cover exposure to asbestos and a variety of other potential […]

The post VA Benefits Now Available to Millions of Veterans appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Renowned Thoracic Surgeon Enhances Mesothelioma Care in FL

Dr. Rodney Landreneau is joining the renowned Thoracic Surgical Program at Tampa General Hospital. He spent decades caring for patients with pleural mesothelioma and lung cancer patients in Western Pennsylvania at the University of Pittsburgh and Penn Highlands Healthcare. He’s now moved more than 1,000 miles to help augment Tampa General Hospital Cancer Institute’s successful […]

The post Renowned Thoracic Surgeon Enhances Mesothelioma Care in FL appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

New Drug to Treat Mesothelioma Hailed as a Major Breakthrough

ADI-PEG20 or pegargiminase is being hailed as the first drug of its kind to be incorporated successfully with chemotherapy in 20 years. Researchers say this new drug could bring hope to thousands of mesothelioma survivors and their families. The drug blocks the cancer’s food supply, ensuring the disease can’t spread. It prevents cancer cells from […]

The post New Drug to Treat Mesothelioma Hailed as a Major Breakthrough appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma

The U.S. Food and Drug Administration granted fast-track designation to a new therapeutic cancer vaccine. The approval is for UV1 in combination with the immunotherapy drugs Opdivo (nivolumab) and Yervoy (ipilimumab) to manage malignant pleural mesothelioma that can’t be managed with surgery. Therapeutic cancer vaccines, unlike preventive vaccines, treat existing cancers. Fast Track expedites the […]

The post FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Polaris Submits Application for New Mesothelioma Treatment

Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application for the experimental drug ADI-PEG 20 is the first step in U.S. Food and Drug Administration approval. The application outlines the use of ADI-PEG 20 for non-epithelioid mesothelioma alongside treatment with pemetrexed […]

The post Polaris Submits Application for New Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone

Results of a new phase 3 clinical trial published in the Journal of Clinical Oncology indicate that a chemoimmunotherapy regimen combining chemotherapy with immunotherapy drugs improves patient survival more than chemotherapy alone for pleural mesothelioma. Study researchers used pembrolizumab (Keytruda) alongside platinum and pemetrexed chemotherapy. Christina S. Baik, MD, MPH, reviewed the phase 3 trial […]

The post Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Libby Clinic Files for Bankruptcy After Asbestos Claims Ruling

The Center for Asbestos Related Disease in Libby, Montana, has filed for Chapter 11 bankruptcy protection. The decision comes after a jury ruled in June that CARD had submitted 337 false asbestos claims, forcing the clinic to pay nearly $6 million in penalties and damages. BNSF Railway filed the lawsuit against CARD under the federal […]

The post Libby Clinic Files for Bankruptcy After Asbestos Claims Ruling appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Mesothelioma Specialty Centers Lead U.S. News Best Hospitals Rankings

U.S. News & World Report has named University of Texas MD Anderson Cancer Center the Best Hospital for Cancer for the ninth year in a row in its annual rankings. The Houston-based hospital is followed by Memorial Sloan Kettering in New York; Mayo Clinic in Rochester, Minnesota; UCLA Medical Center in Los Angeles and Dana-Farber […]

The post Mesothelioma Specialty Centers Lead U.S. News Best Hospitals Rankings appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Mesothelioma Immunotherapy Receives Orphan Drug Designation

A novel therapy for mesothelioma has been given orphan drug designation by the U.S. Food and Drug Administration. Avenge Bio, a biotechnology company working on a new treatment platform for immunotherapy, announced it was granted the designation for its drug AVB-001 in June. It is currently enrolling patients in ongoing phase 1 and phase 2 […]

The post Mesothelioma Immunotherapy Receives Orphan Drug Designation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

CARD Clinic in Libby Designated as Center of Excellence   

Lawmakers in Montana have declared the Center for Asbestos Related Diseases, also known as the CARD Clinic, as a Center of Excellence. The Montana House of Representatives passed a resolution in May 2023 recognizing the clinic’s importance. Lawmakers say the clinic based in Libby, Montana, played a significant role in an asbestos contamination Superfund that […]

The post CARD Clinic in Libby Designated as Center of Excellence appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Netherlands Cancer Institute Tests New Mesothelioma Therapy

Research for a new type of mesothelioma treatment is underway at the Netherlands Cancer Institute. Scientists are exploring a novel combination of existing medications for patients with BAP1 genetic mutations. More than half of all mesothelioma patients show alterations in the BAP1 tumor-suppressor gene. An altered BAP1 gene allows for vulnerabilities that make specific treatments […]

The post Netherlands Cancer Institute Tests New Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Mesothelioma Treatment Uses Natural Immune Cells

For patients with mesothelioma cancer, immunotherapy is a promising new field. Results from a recent study at Rice University in Houston are exciting. Researchers are looking at ways the natural immune system can help fight this cancer. The study examined the therapeutic effects of interleukin 2, a form of immunotherapy for mesothelioma. IL2 is a […]

The post Mesothelioma Treatment Uses Natural Immune Cells appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery

Patients with recurrent mesothelioma cancer often have few options. A new study by the Hyogo College of Medicine in Japan may have a potential answer. This study tested the safety and efficacy of two drugs following mesothelioma surgery after cancer recurrence. The combination of immunotherapy drugs nivolumab and ipilimumab, known by the brand names Opdivo […]

The post Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival

Select patients diagnosed with mesothelioma cancer in both the thoracic and abdominal cavities still can achieve an extended survival if their treatment center performs the preferred types of aggressive surgery, according to a recent study at Baylor College of Medicine in Houston. Patients undergoing bicavitary cytoreductive surgery that includes the lung-sparing, extended pleurectomy and decortication […]

The post Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Looking Beyond Clinical Trials for Mesothelioma Treatment

Clinical trial results should not always be the guiding force when a mesothelioma cancer patient and their medical team determine what therapy path to take, according to one recent study. A look at real-world populations might be just as important. A research team at the University of Pennsylvania Department of Medicine has made the point […]

The post Looking Beyond Clinical Trials for Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]